Cannabis

Recent articles

A photograph of a scientist holding a cannabis plant

Cannabis may be rescheduled–what does it mean for neuroscience?

The drug could become much easier to access, increasing the number of researchers who can work with it and the manufacturers who can produce it.

By Gina Jiménez
22 May 2024 | 6 min read
A hand reaches from above to add a pill to a stack that is resting against the x-axis of a graph.

How organ-on-a-chip models can help drug development

This month’s Going on Trial newsletter explores how organ-on-a-chip models could smooth the transition from preclinical to clinical trials, among other drug development news.

By Calli McMurray
31 July 2023 | 5 min read
Illustration of hybrid objects: part light bulb, part lab vial, some in blue and some in red to signify null and replicated results.

Prenatal exposures; Angelman trial suspension; autistic adult well-being

This month’s issue of the Null and Noteworthy newsletter breaks down some negative results involving prenatal exposures, an experimental treatment for Angelman syndrome, and the role that age at autism diagnosis plays in subsequent outcomes, and more.

By Emily Harris
17 July 2023 | 4 min read
Research image of cultured neurons.

Cannabis compound rebalances signaling to quell seizures in mice

Cannabidiol (CBD) blocks the action of a molecule that drives an overexcitability feedback loop in a rodent model of epilepsy.

By Peter Hess
22 March 2023 | 5 min listen

Explore more from The Transmitter

Stimulating the brain with Damien Fair

The MacArthur Foundation “genius” discusses his return to his home state of Minnesota and why it’s important to protect the developing brain.

By Brady Huggett
3 February 2025 | 68 min listen

Roundup: The false association between vaccines and autism

In light of Robert F. Kennedy Jr.’s U.S. Senate confirmation hearings this week, The Transmitter has rounded up our past coverage of the false association between vaccines and autism.

By The Transmitter
31 January 2025 | 1 min read

Static pay, shrinking prospects fuel neuroscience postdoc decline

Postdoctoral researchers sponsored by the National Institutes of Health now toil longer than ever before, for less money. They are responding accordingly.

By Katie Moisse
31 January 2025 | 20 min read